dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· February 6, 2026

Philip Morris targets 5–7% organic net revenue growth for 2026 while expanding smoke-free leadership

View original at seekingalpha.com
Philip Morris targets 5–7% organic net revenue growth for 2026 while expanding smoke-free leadership Earnings Call Insights: Philip Morris International Inc…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • IQOS showing strong performance in Italy, Germany, Spain, and new markets like Taiwan

    80% confidence
  • 27 markets surpassed the 50% smoke-free net revenue milestone

    80% confidence
  • Total net revenues reached over $40 billion in 2025 with 41.5% or close to $17 billion generated by smoke-free business

    80% confidence
  • Cigarette volume forecast to decline by around 3% in 2026

    80% confidence
  • PMI forecasts 2026 organic net revenue growth of 5% to 7% and organic operating income growth of 7% to 9%

    80% confidence
  • Operating cash flow targeted at around $13.5 billion for 2026

    80% confidence
  • 2025 was another outstanding year for PMI with leadership in smoke-free products and sustained growth

    80% confidence
  • Adjusted diluted EPS of $7.54 was at high end of last guidance range despite lower-than-expected currency tailwind

    80% confidence
  • PMI looks forward with confidence to 2026 and beyond

    80% confidence
  • U.S. market deployed different promotion intensity in Q3 and Q4, with some schemes not repeated by PMI decision

    80% confidence
  • Organic top line and operating income growth were in line with forecast ranges set at start of 2025, and currency-neutral adjusted diluted EPS growth exceeded expectations by 1.7 points

    80% confidence
  • Increased competitive activity in Japan but IQOS strongly holds share and continues growth

    80% confidence
  • Currency-neutral adjusted diluted EPS growth projected at 7.5% to 9.5% for 2026, translating to $8.39 to $8.54 including currency benefits

    80% confidence
  • IQOS drove core performance with both shipments and adjusted IMS growing around 11%

    80% confidence
  • Japan excise tax will cause some IMS shipment distortions with potential consumer buying ahead, but over longer period PMI will achieve targets

    80% confidence
  • Both ZYN ex-Nordics and VEEV more than doubled shipment volumes in international markets

    80% confidence
  • Smoke-free shipment and adjusted IMS volumes expected to grow in high single digits in 2026

    80% confidence
  • PMI ambitions to continue being very efficient on costs and targeting efficiency from AI in the future

    80% confidence
  • State excise tax increases on nicotine pouches would be counterproductive to health benefits these products provide

    80% confidence
  • Excise tax changes in Japan and U.S. regulatory developments for ZYN are key drivers for smoke-free volume growth reacceleration

    80% confidence
  • PMI targets leverage ratio of close to 2x by end of 2026

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Philip Morris targets 5–7% organic net revenue growth for 2026 while expanding smoke-free leadership: Source | Via News | fr.via.news